161 related articles for article (PubMed ID: 36469361)
1. Semaglutide for Weight Loss: Was It Worth the Weight?: Erratum.
Cardiol Rev; 2023 Jan-Feb 01; 31(1):57. PubMed ID: 36469361
[No Abstract] [Full Text] [Related]
2. Oral semaglutide in Japanese versus non-Japanese patients with type 2 diabetes.
Scheen AJ
Lancet Diabetes Endocrinol; 2020 May; 8(5):350-352. PubMed ID: 32333865
[No Abstract] [Full Text] [Related]
3. Add-on value of tirzepatide versus semaglutide.
Scheen AJ
Lancet Diabetes Endocrinol; 2022 Jun; 10(6):377-378. PubMed ID: 35468323
[No Abstract] [Full Text] [Related]
4. Semaglutide for weight loss.
Ojeniran M; Dube B; Paige A; Ton J; Lindblad AJ
Can Fam Physician; 2021 Nov; 67(11):842. PubMed ID: 34772713
[No Abstract] [Full Text] [Related]
5. Oral glucagon-like peptide-receptor agonists (GLP1RA) counseling: comparison with insulin counseling.
Kalra S; Kalhan A; Berard L
Postgrad Med; 2020 Nov; 132(8):663-666. PubMed ID: 32781867
[No Abstract] [Full Text] [Related]
6. Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus.
Cowart K
Ann Pharmacother; 2020 May; 54(5):478-485. PubMed ID: 31744308
[No Abstract] [Full Text] [Related]
7. Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States.
Hunt B; Hansen BB; Ericsson Å; Kallenbach K; Ali SN; Dang-Tan T; Malkin SJP; Valentine WJ
Adv Ther; 2019 Dec; 36(12):3483-3493. PubMed ID: 31650514
[TBL] [Abstract][Full Text] [Related]
8. Once-Weekly Semaglutide with Lifestyle Intervention Results in Clinically Significant Weight Loss.
Chang RS; Hu JR; Yeh HC
J Gen Intern Med; 2022 May; 37(7):1824-1826. PubMed ID: 35230621
[No Abstract] [Full Text] [Related]
9. Wegovy (semaglutide): a new weight loss drug for chronic weight management.
Singh G; Krauthamer M; Bjalme-Evans M
J Investig Med; 2022 Jan; 70(1):5-13. PubMed ID: 34706925
[TBL] [Abstract][Full Text] [Related]
10. A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK.
Johansen P; Sandberg A; Capehorn M
Adv Ther; 2020 Mar; 37(3):1248-1259. PubMed ID: 32048148
[TBL] [Abstract][Full Text] [Related]
11. Semaglutide for Weight Loss.
Carris NW; Dietrich EA
Ann Pharmacother; 2022 Feb; 56(2):224-226. PubMed ID: 34157885
[No Abstract] [Full Text] [Related]
12. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Davies M; Færch L; Jeppesen OK; Pakseresht A; Pedersen SD; Perreault L; Rosenstock J; Shimomura I; Viljoen A; Wadden TA; Lingvay I;
Lancet; 2021 Mar; 397(10278):971-984. PubMed ID: 33667417
[TBL] [Abstract][Full Text] [Related]
13. Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.
Rodbard HW; Lingvay I; Reed J; de la Rosa R; Rose L; Sugimoto D; Araki E; Chu PL; Wijayasinghe N; Norwood P
J Clin Endocrinol Metab; 2018 Jun; 103(6):2291-2301. PubMed ID: 29688502
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control and weight loss with semaglutide in type 2 diabetes.
Madsbad S; Holst JJ
Lancet Diabetes Endocrinol; 2017 May; 5(5):315-317. PubMed ID: 28385658
[No Abstract] [Full Text] [Related]
15. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Frías JP; Davies MJ; Rosenstock J; Pérez Manghi FC; Fernández Landó L; Bergman BK; Liu B; Cui X; Brown K;
N Engl J Med; 2021 Aug; 385(6):503-515. PubMed ID: 34170647
[TBL] [Abstract][Full Text] [Related]
16. Once-Weekly Semaglutide Is an Effective Adjunct for Weight Loss in Adults without Diabetes Who Are Overweight or Obese.
Slawson DC
Am Fam Physician; 2021 Jul; 104(1):96-97. PubMed ID: 34264618
[No Abstract] [Full Text] [Related]
17. Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK.
Johansen P; Chubb B; Hunt B; Malkin SJP; Sandberg A; Capehorn M
Adv Ther; 2020 May; 37(5):2427-2441. PubMed ID: 32306244
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).
Capehorn MS; Catarig AM; Furberg JK; Janez A; Price HC; Tadayon S; Vergès B; Marre M
Diabetes Metab; 2020 Apr; 46(2):100-109. PubMed ID: 31539622
[TBL] [Abstract][Full Text] [Related]
19. Semaglutide in routine clinical practice: interesting news from real-world evidence.
Formoso G; Baroni MG
J Endocrinol Invest; 2022 Aug; 45(8):1599-1600. PubMed ID: 35524036
[No Abstract] [Full Text] [Related]
20. Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus.
Pace E; Tingen J
Am Fam Physician; 2017 Oct; 96(8):540-542. PubMed ID: 29094890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
